West Pharmaceutical Services (WST) ROE: History & Chart

West Pharmaceutical Services, Inc.(WST)

Medical - Instruments & Supplies · Exton, PA

$370.29-3.31 (-0.89%)

Delayed quote: Sep 25, 2026, 4:00 PM EDT

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA

10,800 employees

www.westpharma.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Eric Green

View full financials

WST Return on Equity (ROE) Metrics

RETURN ON EQUITY (ROE)

18.89%

RETURN ON EQUITY (ROE) AVG TTM

17.07%

RETURN ON EQUITY (ROE) AVG 3Y

18.45%

RETURN ON EQUITY (ROE) AVG 5Y

21.26%

RETURN ON EQUITY (ROE) AVG 10Y

17.26%

RETURN ON EQUITY (ROE) AVG 15Y

15.66%

RETURN ON EQUITY (ROE) AVG 20Y

14.77%

CURRENT VS TTM AVG

+10.67%

CURRENT VS 3Y AVG

+2.39%

CURRENT VS 5Y AVG

-11.14%

CURRENT VS 10Y AVG

+9.47%

CURRENT VS 15Y AVG

+20.66%

CURRENT VS 20Y AVG

+27.91%

SECTOR MEDIAN · HEALTHCARE

13.01%

median of 84 covered companies

CURRENT VS SECTOR MEDIAN

+45.21%

vs the sector median at left

NAME	MARKET CAP	RETURN ON EQUITY (ROE)	TTM	3Y	5Y
West Pharmaceutical Services, Inc. (WST)	$26.06B	18.89%	17.07%	18.45%	21.26%
Quest Diagnostics Incorporated (DGX)vs ›	$26.08B	14.13%	13.34%	14.07%	18.07%
Labcorp Holdings Inc. (LH)vs ›	$25.39B	11.65%	9.71%	9.35%	12.84%
Incyte Corporation (INCY)vs ›	$25.11B	25.41%	12.92%	11.29%	9.83%
BioNTech SE (BNTX)vs ›	$24.75B	-9.62%	-4.55%	10.63%	21.70%
Medline Inc. (MDLN)vs ›	$29.34B	5.97%	9.02%	4.86%	4.86%
Zoetis Inc. (ZTS)vs ›	$29.79B	83.10%	66.19%	56.82%	52.60%
GE HealthCare Technologies Inc. (GEHC)vs ›	$30.10B	14.51%	21.84%	21.53%	32.27%
Centene Corp. (CNC)vs ›	$30.53B	-22.60%	-10.46%	-1.37%	1.10%
Mettler-Toledo International Inc. (MTD)vs ›	$30.55B	7062.40%	-2178.82%	-341.14%	-117.12%

NAME

MARKET CAP

RETURN ON EQUITY (ROE)

TTM

West Pharmaceutical Services, Inc. (WST)

$26.06B

18.89%

17.07%

18.45%

21.26%

Quest Diagnostics Incorporated (DGX)vs ›

$26.08B

14.13%

13.34%

14.07%

18.07%

Labcorp Holdings Inc. (LH)vs ›

$25.39B

11.65%

9.71%

9.35%

12.84%

Incyte Corporation (INCY)vs ›

$25.11B

25.41%

12.92%

11.29%

9.83%

BioNTech SE (BNTX)vs ›

$24.75B

-9.62%

-4.55%

10.63%

21.70%

Medline Inc. (MDLN)vs ›

$29.34B

5.97%

9.02%

4.86%

Zoetis Inc. (ZTS)vs ›

$29.79B

83.10%

66.19%

56.82%

52.60%

GE HealthCare Technologies Inc. (GEHC)vs ›

$30.10B

14.51%

21.84%

21.53%

32.27%

Centene Corp. (CNC)vs ›

$30.53B

-22.60%

-10.46%

-1.37%

1.10%

Mettler-Toledo International Inc. (MTD)vs ›

$30.55B

7062.40%

-2178.82%

-341.14%

-117.12%

Return on Equity (ROE) FAQ

What is the return on equity (ROE) for West Pharmaceutical Services, Inc. (WST)?

The return on equity (ROE) for WST stock is 18.89%.

Is West Pharmaceutical Services, Inc.'s return on equity (ROE) high or low?

The return on equity (ROE) of 18.89% is 11% below its 5-year average of 21.26%, near the low end of its 5-year range (15.54%–29.42%).

What is the TTM average return on equity (ROE) for West Pharmaceutical Services, Inc. (WST)?

The TTM average return on equity (ROE) for WST stock is 17.07%.

What is the 3Y average return on equity (ROE) for West Pharmaceutical Services, Inc. (WST)?

The 3Y average return on equity (ROE) for WST stock is 18.45%.

What is the 5Y average return on equity (ROE) for West Pharmaceutical Services, Inc. (WST)?

The 5Y average return on equity (ROE) for WST stock is 21.26%.

What is the 10Y average return on equity (ROE) for West Pharmaceutical Services, Inc. (WST)?

The 10Y average return on equity (ROE) for WST stock is 17.26%.

What is the 15Y average return on equity (ROE) for West Pharmaceutical Services, Inc. (WST)?

The 15Y average return on equity (ROE) for WST stock is 15.66%.

What is the 20Y average return on equity (ROE) for West Pharmaceutical Services, Inc. (WST)?

The 20Y average return on equity (ROE) for WST stock is 14.77%.

DATE	RETURN ON EQUITY (ROE)
2026-06-30	18.89%
2026-03-31	18.15%
2025-12-31	15.54%
2025-09-30	16.11%
2025-06-30	16.65%
2025-03-31	17.41%
2024-12-31	18.37%
2024-09-30	18.15%
2024-06-30	20.37%
2024-03-31	21.22%
2023-12-31	20.60%
2023-09-30	19.50%
2023-06-30	18.88%
2023-03-31	19.89%
2022-12-31	21.82%
2022-09-30	25.52%
2022-06-30	28.28%
2022-03-31	29.42%
2021-12-31	28.34%
2021-09-30	27.81%
2021-06-30	25.54%
2021-03-31	23.13%
2020-12-31	18.67%
2020-09-30	18.13%
2020-06-30	17.79%
2020-03-31	17.49%
2019-12-31	15.36%
2019-09-30	15.45%
2019-06-30	15.83%
2019-03-31	15.93%
2018-12-31	14.82%
2018-09-30	11.27%
2018-06-30	11.56%
2018-03-31	10.03%
2017-12-31	11.58%
2017-09-30	14.41%
2017-06-30	14.20%
2017-03-31	15.60%
2016-12-31	12.84%
2016-09-30	12.06%
2016-06-30	9.17%
2016-03-31	7.90%
2015-12-31	9.34%
2015-09-30	9.40%
2015-06-30	12.44%
2015-03-31	14.12%
2014-12-31	13.28%
2014-09-30	12.30%
2014-06-30	11.83%
2014-03-31	11.52%
2013-12-31	12.39%
2013-09-30	13.12%
2013-06-30	12.47%
2013-03-31	11.15%
2012-12-31	11.07%
2012-09-30	10.93%
2012-06-30	11.85%
2012-03-31	12.24%
2011-12-31	11.51%
2011-09-30	9.06%
2011-06-30	9.12%
2011-03-31	9.82%
2010-12-31	10.44%
2010-09-30	12.59%
2010-06-30	13.84%
2010-03-31	13.28%
2009-12-31	12.54%
2009-09-30	12.37%
2009-06-30	12.40%
2009-03-31	15.37%
2008-12-31	17.63%
2008-09-30	13.93%
2008-08-05	13.37%
2008-03-31	13.80%
2007-12-31	14.57%
2007-09-30	16.55%
2007-06-30	16.35%
2007-03-31	16.43%
2006-12-31	16.19%
2006-09-30	15.81%
2006-06-30	15.01%
2006-03-31	13.93%
2005-12-31	13.67%
2005-09-30	10.54%
2005-06-30	9.77%
2005-03-31	8.35%
2004-12-31	6.44%
2004-09-30	12.85%
2004-06-30	13.18%
2004-03-31	13.34%
2003-12-31	12.38%
2003-09-30	8.07%
2003-06-30	7.98%

DATE

RETURN ON EQUITY (ROE)

2026-06-30

18.89%

2026-03-31

18.15%

2025-12-31

15.54%

2025-09-30

16.11%

2025-06-30

16.65%

2025-03-31

17.41%

2024-12-31

18.37%

2024-09-30

18.15%

2024-06-30

20.37%

2024-03-31

21.22%

2023-12-31

20.60%

2023-09-30

19.50%

2023-06-30

18.88%

2023-03-31

19.89%

2022-12-31

21.82%

2022-09-30

25.52%

2022-06-30

28.28%

2022-03-31

29.42%

2021-12-31

28.34%

2021-09-30

27.81%

2021-06-30

25.54%

2021-03-31

23.13%

2020-12-31

18.67%

2020-09-30

18.13%

2020-06-30

17.79%

2020-03-31

17.49%

2019-12-31

15.36%

2019-09-30

15.45%

2019-06-30

15.83%

2019-03-31

15.93%

2018-12-31

14.82%

2018-09-30

11.27%

2018-06-30

11.56%

2018-03-31

10.03%

2017-12-31

11.58%

2017-09-30

14.41%

2017-06-30

14.20%

2017-03-31

15.60%

2016-12-31

12.84%

2016-09-30

12.06%

2016-06-30

9.17%

2016-03-31

7.90%

2015-12-31

9.34%

2015-09-30

9.40%

2015-06-30

12.44%

2015-03-31

14.12%

2014-12-31

13.28%

2014-09-30

12.30%

2014-06-30

11.83%

2014-03-31

11.52%

2013-12-31

12.39%

2013-09-30

13.12%

2013-06-30

12.47%

2013-03-31

11.15%

2012-12-31

11.07%

2012-09-30

10.93%

2012-06-30

11.85%

2012-03-31

12.24%

2011-12-31

11.51%

2011-09-30

9.06%

2011-06-30

9.12%

2011-03-31

9.82%

2010-12-31

10.44%

2010-09-30

12.59%

2010-06-30

13.84%

2010-03-31

13.28%

2009-12-31

12.54%

2009-09-30

12.37%

2009-06-30

12.40%

2009-03-31

15.37%

2008-12-31

17.63%

2008-09-30

13.93%

2008-08-05

13.37%

2008-03-31

13.80%

2007-12-31

14.57%

2007-09-30

16.55%

2007-06-30

16.35%

2007-03-31

16.43%

2006-12-31

16.19%

2006-09-30

15.81%

2006-06-30

15.01%

2006-03-31

13.93%

2005-12-31

13.67%

2005-09-30

10.54%

2005-06-30

9.77%

2005-03-31

8.35%

2004-12-31

6.44%

2004-09-30

12.85%

2004-06-30

13.18%

2004-03-31

13.34%

2003-12-31

12.38%

2003-09-30

8.07%

2003-06-30

7.98%

Return on Equity (ROE): 18.89%

WST Return on Equity (ROE)

WST Average Return on Equity (ROE) Chart

WST Current vs Average Return on Equity (ROE) Chart

WST Return on Equity (ROE) Metrics

WST Competitors' Return on Equity (ROE)

Return Analysis

Return on Equity (ROE) Formula & Definition

Return on Equity (ROE) FAQ

WST Return on Equity (ROE) History

Related Metrics